INTERNATIONAL JOURNAL OF DERMATOLOGY, cilt.59, sa.7, ss.851-855, 2020 (SCI-Expanded)
Background Epidermolysis bullosa pruriginosa (EBP) is rare a clinical variant of dystrophic epidermolysis bullosa characterized by trauma-induced bullae formation, milia and nail dystrophy accompanied by severe pruritus. Treatment pruritus of EBP focuses on immunosuppressive treatment with limited efficacy. Treatment strategies are not well-established.